Evaluation and comparison of safety, convenience and cost of administering intravenous pamidronate infusions to children in the home and ambulatory care settings

Eric T. Rush, Kristi DeHaai, Rose M. Kreikemeier, Richard E Lutz

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The use of bisphosphonates in children to treat low bone mineral density has increased. Safety and efficacy of pamidronate has been previously demonstrated. However, little research has been done on pamidronate infusion in the home health setting for patients with metabolic bone disease. Data were collected via a survey to assess satisfaction and convenience of infusions. Adverse events were measured by collecting calcium levels before and after infusions. Infusion costs were estimated from the standard orders from one home health agency and our infusion center. We found no difference in the rates of hypocalcemia between the two groups. The survey results showed high satisfaction for both groups, with higher scores in the home health group for convenience and stress. Home health infusions showed lower cost and less absenteeism from school and work. Home health-based pamidronate infusion appears to be safe, less expensive, and is associated with high patient satisfaction.

Original languageEnglish (US)
Pages (from-to)493-497
Number of pages5
JournalJournal of Pediatric Endocrinology and Metabolism
Volume25
Issue number5-6
DOIs
StatePublished - Jun 1 2012

Fingerprint

pamidronate
Home Care Services
Ambulatory Care
Intravenous Infusions
Safety
Costs and Cost Analysis
Health
Home Care Agencies
Group Homes
Absenteeism
Hypocalcemia
Metabolic Bone Diseases
Diphosphonates
Patient Satisfaction
Bone Density
Calcium
Research

Keywords

  • Bone mineral density
  • Healthcare economics
  • Home infusion
  • Osteogenesis imperfecta
  • Osteoporosis
  • Pamidronate
  • Pediatric metabolic bone diseases

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Evaluation and comparison of safety, convenience and cost of administering intravenous pamidronate infusions to children in the home and ambulatory care settings. / Rush, Eric T.; DeHaai, Kristi; Kreikemeier, Rose M.; Lutz, Richard E.

In: Journal of Pediatric Endocrinology and Metabolism, Vol. 25, No. 5-6, 01.06.2012, p. 493-497.

Research output: Contribution to journalArticle

@article{21ffa42f3b6241c2ab4a3379e175d5f9,
title = "Evaluation and comparison of safety, convenience and cost of administering intravenous pamidronate infusions to children in the home and ambulatory care settings",
abstract = "The use of bisphosphonates in children to treat low bone mineral density has increased. Safety and efficacy of pamidronate has been previously demonstrated. However, little research has been done on pamidronate infusion in the home health setting for patients with metabolic bone disease. Data were collected via a survey to assess satisfaction and convenience of infusions. Adverse events were measured by collecting calcium levels before and after infusions. Infusion costs were estimated from the standard orders from one home health agency and our infusion center. We found no difference in the rates of hypocalcemia between the two groups. The survey results showed high satisfaction for both groups, with higher scores in the home health group for convenience and stress. Home health infusions showed lower cost and less absenteeism from school and work. Home health-based pamidronate infusion appears to be safe, less expensive, and is associated with high patient satisfaction.",
keywords = "Bone mineral density, Healthcare economics, Home infusion, Osteogenesis imperfecta, Osteoporosis, Pamidronate, Pediatric metabolic bone diseases",
author = "Rush, {Eric T.} and Kristi DeHaai and Kreikemeier, {Rose M.} and Lutz, {Richard E}",
year = "2012",
month = "6",
day = "1",
doi = "10.1515/jpem-2011-0498",
language = "English (US)",
volume = "25",
pages = "493--497",
journal = "Journal of Pediatric Endocrinology and Metabolism",
issn = "0334-018X",
publisher = "Walter de Gruyter GmbH & Co. KG",
number = "5-6",

}

TY - JOUR

T1 - Evaluation and comparison of safety, convenience and cost of administering intravenous pamidronate infusions to children in the home and ambulatory care settings

AU - Rush, Eric T.

AU - DeHaai, Kristi

AU - Kreikemeier, Rose M.

AU - Lutz, Richard E

PY - 2012/6/1

Y1 - 2012/6/1

N2 - The use of bisphosphonates in children to treat low bone mineral density has increased. Safety and efficacy of pamidronate has been previously demonstrated. However, little research has been done on pamidronate infusion in the home health setting for patients with metabolic bone disease. Data were collected via a survey to assess satisfaction and convenience of infusions. Adverse events were measured by collecting calcium levels before and after infusions. Infusion costs were estimated from the standard orders from one home health agency and our infusion center. We found no difference in the rates of hypocalcemia between the two groups. The survey results showed high satisfaction for both groups, with higher scores in the home health group for convenience and stress. Home health infusions showed lower cost and less absenteeism from school and work. Home health-based pamidronate infusion appears to be safe, less expensive, and is associated with high patient satisfaction.

AB - The use of bisphosphonates in children to treat low bone mineral density has increased. Safety and efficacy of pamidronate has been previously demonstrated. However, little research has been done on pamidronate infusion in the home health setting for patients with metabolic bone disease. Data were collected via a survey to assess satisfaction and convenience of infusions. Adverse events were measured by collecting calcium levels before and after infusions. Infusion costs were estimated from the standard orders from one home health agency and our infusion center. We found no difference in the rates of hypocalcemia between the two groups. The survey results showed high satisfaction for both groups, with higher scores in the home health group for convenience and stress. Home health infusions showed lower cost and less absenteeism from school and work. Home health-based pamidronate infusion appears to be safe, less expensive, and is associated with high patient satisfaction.

KW - Bone mineral density

KW - Healthcare economics

KW - Home infusion

KW - Osteogenesis imperfecta

KW - Osteoporosis

KW - Pamidronate

KW - Pediatric metabolic bone diseases

UR - http://www.scopus.com/inward/record.url?scp=84865613721&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865613721&partnerID=8YFLogxK

U2 - 10.1515/jpem-2011-0498

DO - 10.1515/jpem-2011-0498

M3 - Article

C2 - 22876544

AN - SCOPUS:84865613721

VL - 25

SP - 493

EP - 497

JO - Journal of Pediatric Endocrinology and Metabolism

JF - Journal of Pediatric Endocrinology and Metabolism

SN - 0334-018X

IS - 5-6

ER -